BRCA1 and neoplasm: Furthermore, he has studied histone deacetylase 8 (HDAC8), BRCA1, YWHAE-FAME22 rearrangement, Cyclin D1, tumor cell necrosis (TCN), and BCRO as diagnostic markers for uLMS.